SCHEMBL6509628

SCHEMBL6509628

COC(=O)C(COc1ccc(Cl)cc1)c1ccc(OCc2ccccc2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 2/20 0.51
POLB P06746 2/20 0.51
MEN1 O00255 1/20 0.51
MAPK1 P28482 1/20 0.51
KMT2A Q03164 1/20 0.51
NPSR1 Q6W5P4 1/20 0.51
FFAR1 O14842 1/20 0.50
PRKCA P17252 2/20 0.49
PRKCD Q05655 2/20 0.49
NPC1 O15118 3/20 0.49
RAB9A P51151 3/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
NR4A2 P43354 1/20 0.49
FNTA P49354 1/20 0.48
FNTB P49356 1/20 0.48
MRGPRX4 Q96LA9 1/20 0.48
MAOA P21397 1/20 0.48
MAOB P27338 1/20 0.48
GPR34 Q9UPC5 1/20 0.47
ALDH1A1 P00352 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11565802 0.80 ACACB (0.52) LTA4HPOLBMEN1MAPK1KMT2A
SCHEMBL1069341 0.80 LTA4H (0.53) LTA4HNPC1RAB9ASMN1; SMN2ALOX5
SCHEMBL6849158 0.80 LTA4H (0.53) LTA4HFFAR1PRKCAPRKCDNPC1
SCHEMBL3251101 0.79 LTA4H (0.57) LTA4HFFAR1PRKCAPRKCDNPC1
SCHEMBL10410136 0.79 LTA4H (0.52) LTA4HNPC1RAB9ASMN1; SMN2ALOX5
SCHEMBL6848701 0.79 LTA4H (0.52) LTA4HFFAR1PRKCAPRKCDNPC1
SCHEMBL14021656 0.79 ESR1 (0.72) LTA4HMEN1KMT2AFFAR1NPC1
SCHEMBL31579489 0.79 LTA4H (0.60) LTA4HFFAR1PRKCAPRKCDNPC1
SCHEMBL27108628 0.78 LTA4H (0.51) LTA4HFFAR1PRKCAPRKCDNPC1
SCHEMBL2840120 0.78 LTA4H (0.59) LTA4HFFAR1PRKCAPRKCDNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050020684-A1 Modulators of peroxisome proliferator activated receptors ELI LILLY AND COMPANY 2005-01-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050020684-A1 Modulators of peroxisome proliferator activated receptors NCOA4, PPARG, PPARA LTA4H 2072/4885POLB 2598/4885MEN1 4860/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.